Global Oral Transmucosal Drugs Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Oral Transmucosal Drugs Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Oral Transmucosal Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Tablets
  • 1.2.3 Films
  • 1.2.4 Liquid Spray
  • 1.2.5 Gels
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Oral Transmucosal Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Cardiovascular Disorders
  • 1.3.3 Acute Pain Managements
  • 1.3.4 Diabetes
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Oral Transmucosal Drugs Sales Estimates and Forecasts 2017-2028
• 2.2 Global Oral Transmucosal Drugs Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Oral Transmucosal Drugs Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Oral Transmucosal Drugs Sales by Region
  • 2.4.1 Global Oral Transmucosal Drugs Sales by Region (2017-2022)
  • 2.4.2 Global Sales Oral Transmucosal Drugs by Region (2023-2028)
• 2.5 Global Oral Transmucosal Drugs Revenue by Region
  • 2.5.1 Global Oral Transmucosal Drugs Revenue by Region (2017-2022)
  • 2.5.2 Global Oral Transmucosal Drugs Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Oral Transmucosal Drugs Sales by Manufacturers
  • 3.1.1 Global Top Oral Transmucosal Drugs Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Oral Transmucosal Drugs Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Transmucosal Drugs in 2021
• 3.2 Global Oral Transmucosal Drugs Revenue by Manufacturers
  • 3.2.1 Global Oral Transmucosal Drugs Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Oral Transmucosal Drugs Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Oral Transmucosal Drugs Revenue in 2021
• 3.3 Global Oral Transmucosal Drugs Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Oral Transmucosal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Oral Transmucosal Drugs Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Oral Transmucosal Drugs Sales by Type
  • 4.1.1 Global Oral Transmucosal Drugs Historical Sales by Type (2017-2022)
  • 4.1.2 Global Oral Transmucosal Drugs Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Oral Transmucosal Drugs Sales Market Share by Type (2017-2028)
• 4.2 Global Oral Transmucosal Drugs Revenue by Type
  • 4.2.1 Global Oral Transmucosal Drugs Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Oral Transmucosal Drugs Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Oral Transmucosal Drugs Revenue Market Share by Type (2017-2028)
• 4.3 Global Oral Transmucosal Drugs Price by Type
  • 4.3.1 Global Oral Transmucosal Drugs Price by Type (2017-2022)
  • 4.3.2 Global Oral Transmucosal Drugs Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Oral Transmucosal Drugs Sales by Application
  • 5.1.1 Global Oral Transmucosal Drugs Historical Sales by Application (2017-2022)
  • 5.1.2 Global Oral Transmucosal Drugs Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Oral Transmucosal Drugs Sales Market Share by Application (2017-2028)
• 5.2 Global Oral Transmucosal Drugs Revenue by Application
  • 5.2.1 Global Oral Transmucosal Drugs Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Oral Transmucosal Drugs Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Oral Transmucosal Drugs Revenue Market Share by Application (2017-2028)
• 5.3 Global Oral Transmucosal Drugs Price by Application
  • 5.3.1 Global Oral Transmucosal Drugs Price by Application (2017-2022)
  • 5.3.2 Global Oral Transmucosal Drugs Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Oral Transmucosal Drugs Market Size by Type
  • 6.1.1 North America Oral Transmucosal Drugs Sales by Type (2017-2028)
  • 6.1.2 North America Oral Transmucosal Drugs Revenue by Type (2017-2028)
• 6.2 North America Oral Transmucosal Drugs Market Size by Application
  • 6.2.1 North America Oral Transmucosal Drugs Sales by Application (2017-2028)
  • 6.2.2 North America Oral Transmucosal Drugs Revenue by Application (2017-2028)
• 6.3 North America Oral Transmucosal Drugs Market Size by Country
  • 6.3.1 North America Oral Transmucosal Drugs Sales by Country (2017-2028)
  • 6.3.2 North America Oral Transmucosal Drugs Revenue by Country (2017-2028)
  • 6.3.3 United States
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Oral Transmucosal Drugs Market Size by Type
  • 7.1.1 Europe Oral Transmucosal Drugs Sales by Type (2017-2028)
  • 7.1.2 Europe Oral Transmucosal Drugs Revenue by Type (2017-2028)
• 7.2 Europe Oral Transmucosal Drugs Market Size by Application
  • 7.2.1 Europe Oral Transmucosal Drugs Sales by Application (2017-2028)
  • 7.2.2 Europe Oral Transmucosal Drugs Revenue by Application (2017-2028)
• 7.3 Europe Oral Transmucosal Drugs Market Size by Country
  • 7.3.1 Europe Oral Transmucosal Drugs Sales by Country (2017-2028)
  • 7.3.2 Europe Oral Transmucosal Drugs Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Oral Transmucosal Drugs Market Size by Type
  • 8.1.1 Asia Pacific Oral Transmucosal Drugs Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Oral Transmucosal Drugs Revenue by Type (2017-2028)
• 8.2 Asia Pacific Oral Transmucosal Drugs Market Size by Application
  • 8.2.1 Asia Pacific Oral Transmucosal Drugs Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Oral Transmucosal Drugs Revenue by Application (2017-2028)
• 8.3 Asia Pacific Oral Transmucosal Drugs Market Size by Region
  • 8.3.1 Asia Pacific Oral Transmucosal Drugs Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Oral Transmucosal Drugs Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 China Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia

9 Latin America

• 9.1 Latin America Oral Transmucosal Drugs Market Size by Type
  • 9.1.1 Latin America Oral Transmucosal Drugs Sales by Type (2017-2028)
  • 9.1.2 Latin America Oral Transmucosal Drugs Revenue by Type (2017-2028)
• 9.2 Latin America Oral Transmucosal Drugs Market Size by Application
  • 9.2.1 Latin America Oral Transmucosal Drugs Sales by Application (2017-2028)
  • 9.2.2 Latin America Oral Transmucosal Drugs Revenue by Application (2017-2028)
• 9.3 Latin America Oral Transmucosal Drugs Market Size by Country
  • 9.3.1 Latin America Oral Transmucosal Drugs Sales by Country (2017-2028)
  • 9.3.2 Latin America Oral Transmucosal Drugs Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Oral Transmucosal Drugs Market Size by Type
  • 10.1.1 Middle East and Africa Oral Transmucosal Drugs Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Oral Transmucosal Drugs Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Oral Transmucosal Drugs Market Size by Application
  • 10.2.1 Middle East and Africa Oral Transmucosal Drugs Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Oral Transmucosal Drugs Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Oral Transmucosal Drugs Market Size by Country
  • 10.3.1 Middle East and Africa Oral Transmucosal Drugs Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Oral Transmucosal Drugs Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 LTS Lohmann Therapie-Systeme AG
  • 11.1.1 LTS Lohmann Therapie-Systeme AG Corporation Information
  • 11.1.2 LTS Lohmann Therapie-Systeme AG Overview
  • 11.1.3 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 LTS Lohmann Therapie-Systeme AG Recent Developments
• 11.2 Soligenix
  • 11.2.1 Soligenix Corporation Information
  • 11.2.2 Soligenix Overview
  • 11.2.3 Soligenix Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 Soligenix Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Soligenix Recent Developments
• 11.3 ZIM Laboratories Limited
  • 11.3.1 ZIM Laboratories Limited Corporation Information
  • 11.3.2 ZIM Laboratories Limited Overview
  • 11.3.3 ZIM Laboratories Limited Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 ZIM Laboratories Limited Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 ZIM Laboratories Limited Recent Developments
• 11.4 Access Pharmaceutical Inc.
  • 11.4.1 Access Pharmaceutical Inc. Corporation Information
  • 11.4.2 Access Pharmaceutical Inc. Overview
  • 11.4.3 Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 Access Pharmaceutical Inc. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Access Pharmaceutical Inc. Recent Developments
• 11.5 C.L Pharm
  • 11.5.1 C.L Pharm Corporation Information
  • 11.5.2 C.L Pharm Overview
  • 11.5.3 C.L Pharm Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 C.L Pharm Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 C.L Pharm Recent Developments
• 11.6 Cure Pharmaceutical
  • 11.6.1 Cure Pharmaceutical Corporation Information
  • 11.6.2 Cure Pharmaceutical Overview
  • 11.6.3 Cure Pharmaceutical Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Cure Pharmaceutical Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Cure Pharmaceutical Recent Developments
• 11.7 Aquestive Therapeutics, Inc.
  • 11.7.1 Aquestive Therapeutics, Inc. Corporation Information
  • 11.7.2 Aquestive Therapeutics, Inc. Overview
  • 11.7.3 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Aquestive Therapeutics, Inc. Recent Developments
• 11.8 NAL Pharma
  • 11.8.1 NAL Pharma Corporation Information
  • 11.8.2 NAL Pharma Overview
  • 11.8.3 NAL Pharma Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 NAL Pharma Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 NAL Pharma Recent Developments
• 11.9 IntelGenx Corp.
  • 11.9.1 IntelGenx Corp. Corporation Information
  • 11.9.2 IntelGenx Corp. Overview
  • 11.9.3 IntelGenx Corp. Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 IntelGenx Corp. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 IntelGenx Corp. Recent Developments
• 11.10 Eisai Co., Ltd.
  • 11.10.1 Eisai Co., Ltd. Corporation Information
  • 11.10.2 Eisai Co., Ltd. Overview
  • 11.10.3 Eisai Co., Ltd. Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 Eisai Co., Ltd. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Eisai Co., Ltd. Recent Developments
• 11.11 Otsuka Pharmaceutical Co., Ltd.
  • 11.11.1 Otsuka Pharmaceutical Co., Ltd. Corporation Information
  • 11.11.2 Otsuka Pharmaceutical Co., Ltd. Overview
  • 11.11.3 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.11.4 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments
• 11.12 Teva Pharmaceutical Industries Ltd.
  • 11.12.1 Teva Pharmaceutical Industries Ltd. Corporation Information
  • 11.12.2 Teva Pharmaceutical Industries Ltd. Overview
  • 11.12.3 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.12.4 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Teva Pharmaceutical Industries Ltd. Recent Developments
• 11.13 GlaxoSmithKline plc
  • 11.13.1 GlaxoSmithKline plc Corporation Information
  • 11.13.2 GlaxoSmithKline plc Overview
  • 11.13.3 GlaxoSmithKline plc Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.13.4 GlaxoSmithKline plc Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 GlaxoSmithKline plc Recent Developments
• 11.14 Viatris
  • 11.14.1 Viatris Corporation Information
  • 11.14.2 Viatris Overview
  • 11.14.3 Viatris Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.14.4 Viatris Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.14.5 Viatris Recent Developments
• 11.15 Bristol-Myers Squibb Company
  • 11.15.1 Bristol-Myers Squibb Company Corporation Information
  • 11.15.2 Bristol-Myers Squibb Company Overview
  • 11.15.3 Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.15.4 Bristol-Myers Squibb Company Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.15.5 Bristol-Myers Squibb Company Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Oral Transmucosal Drugs Industry Chain Analysis
• 12.2 Oral Transmucosal Drugs Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Oral Transmucosal Drugs Production Mode & Process
• 12.4 Oral Transmucosal Drugs Sales and Marketing
  • 12.4.1 Oral Transmucosal Drugs Sales Channels
  • 12.4.2 Oral Transmucosal Drugs Distributors
• 12.5 Oral Transmucosal Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Oral Transmucosal Drugs Industry Trends
• 13.2 Oral Transmucosal Drugs Market Drivers
• 13.3 Oral Transmucosal Drugs Market Challenges
• 13.4 Oral Transmucosal Drugs Market Restraints

14 Key Findings in The Global Oral Transmucosal Drugs Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Oral Transmucosal Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Tablets
• Table 3. Major Manufacturers of Films
• Table 4. Major Manufacturers of Liquid Spray
• Table 5. Major Manufacturers of Gels
• Table 6. Major Manufacturers of Others
• Table 7. Global Oral Transmucosal Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 8. Global Oral Transmucosal Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 9. Global Oral Transmucosal Drugs Sales by Region (2017-2022) & (K Units)
• Table 10. Global Oral Transmucosal Drugs Sales Market Share by Region (2017-2022)
• Table 11. Global Oral Transmucosal Drugs Sales by Region (2023-2028) & (K Units)
• Table 12. Global Oral Transmucosal Drugs Sales Market Share by Region (2023-2028)
• Table 13. Global Oral Transmucosal Drugs Revenue by Region (2017-2022) & (US$ Million)
• Table 14. Global Oral Transmucosal Drugs Revenue Market Share by Region (2017-2022)
• Table 15. Global Oral Transmucosal Drugs Revenue by Region (2023-2028) & (US$ Million)
• Table 16. Global Oral Transmucosal Drugs Revenue Market Share by Region (2023-2028)
• Table 17. Global Oral Transmucosal Drugs Sales by Manufacturers (2017-2022) & (K Units)
• Table 18. Global Oral Transmucosal Drugs Sales Share by Manufacturers (2017-2022)
• Table 19. Global Oral Transmucosal Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 20. Global Oral Transmucosal Drugs Revenue Share by Manufacturers (2017-2022)
• Table 21. Oral Transmucosal Drugs Price by Manufacturers (2017-2022) &(US$/Unit)
• Table 22. Global Oral Transmucosal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 23. Global Oral Transmucosal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Transmucosal Drugs as of 2021)
• Table 24. Oral Transmucosal Drugs Manufacturing Base Distribution and Headquarters
• Table 25. Manufacturers Oral Transmucosal Drugs Product Offered
• Table 26. Date of Manufacturers Enter into Oral Transmucosal Drugs Market
• Table 27. Mergers & Acquisitions, Expansion Plans
• Table 28. Global Oral Transmucosal Drugs Sales by Type (2017-2022) & (K Units)
• Table 29. Global Oral Transmucosal Drugs Sales by Type (2023-2028) & (K Units)
• Table 30. Global Oral Transmucosal Drugs Sales Share by Type (2017-2022)
• Table 31. Global Oral Transmucosal Drugs Sales Share by Type (2023-2028)
• Table 32. Global Oral Transmucosal Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 33. Global Oral Transmucosal Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 34. Global Oral Transmucosal Drugs Revenue Share by Type (2017-2022)
• Table 35. Global Oral Transmucosal Drugs Revenue Share by Type (2023-2028)
• Table 36. Oral Transmucosal Drugs Price by Type (2017-2022) & (US$/Unit)
• Table 37. Global Oral Transmucosal Drugs Price Forecast by Type (2023-2028) & (US$/Unit)
• Table 38. Global Oral Transmucosal Drugs Sales by Application (2017-2022) & (K Units)
• Table 39. Global Oral Transmucosal Drugs Sales by Application (2023-2028) & (K Units)
• Table 40. Global Oral Transmucosal Drugs Sales Share by Application (2017-2022)
• Table 41. Global Oral Transmucosal Drugs Sales Share by Application (2023-2028)
• Table 42. Global Oral Transmucosal Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 43. Global Oral Transmucosal Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 44. Global Oral Transmucosal Drugs Revenue Share by Application (2017-2022)
• Table 45. Global Oral Transmucosal Drugs Revenue Share by Application (2023-2028)
• Table 46. Oral Transmucosal Drugs Price by Application (2017-2022) & (US$/Unit)
• Table 47. Global Oral Transmucosal Drugs Price Forecast by Application (2023-2028) & (US$/Unit)
• Table 48. North America Oral Transmucosal Drugs Sales by Type (2017-2022) & (K Units)
• Table 49. North America Oral Transmucosal Drugs Sales by Type (2023-2028) & (K Units)
• Table 50. North America Oral Transmucosal Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 51. North America Oral Transmucosal Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 52. North America Oral Transmucosal Drugs Sales by Application (2017-2022) & (K Units)
• Table 53. North America Oral Transmucosal Drugs Sales by Application (2023-2028) & (K Units)
• Table 54. North America Oral Transmucosal Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 55. North America Oral Transmucosal Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 56. North America Oral Transmucosal Drugs Sales by Country (2017-2022) & (K Units)
• Table 57. North America Oral Transmucosal Drugs Sales by Country (2023-2028) & (K Units)
• Table 58. North America Oral Transmucosal Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 59. North America Oral Transmucosal Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 60. Europe Oral Transmucosal Drugs Sales by Type (2017-2022) & (K Units)
• Table 61. Europe Oral Transmucosal Drugs Sales by Type (2023-2028) & (K Units)
• Table 62. Europe Oral Transmucosal Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 63. Europe Oral Transmucosal Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 64. Europe Oral Transmucosal Drugs Sales by Application (2017-2022) & (K Units)
• Table 65. Europe Oral Transmucosal Drugs Sales by Application (2023-2028) & (K Units)
• Table 66. Europe Oral Transmucosal Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 67. Europe Oral Transmucosal Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 68. Europe Oral Transmucosal Drugs Sales by Country (2017-2022) & (K Units)
• Table 69. Europe Oral Transmucosal Drugs Sales by Country (2023-2028) & (K Units)
• Table 70. Europe Oral Transmucosal Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 71. Europe Oral Transmucosal Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 72. Asia Pacific Oral Transmucosal Drugs Sales by Type (2017-2022) & (K Units)
• Table 73. Asia Pacific Oral Transmucosal Drugs Sales by Type (2023-2028) & (K Units)
• Table 74. Asia Pacific Oral Transmucosal Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 75. Asia Pacific Oral Transmucosal Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 76. Asia Pacific Oral Transmucosal Drugs Sales by Application (2017-2022) & (K Units)
• Table 77. Asia Pacific Oral Transmucosal Drugs Sales by Application (2023-2028) & (K Units)
• Table 78. Asia Pacific Oral Transmucosal Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 79. Asia Pacific Oral Transmucosal Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 80. Asia Pacific Oral Transmucosal Drugs Sales by Region (2017-2022) & (K Units)
• Table 81. Asia Pacific Oral Transmucosal Drugs Sales by Region (2023-2028) & (K Units)
• Table 82. Asia Pacific Oral Transmucosal Drugs Revenue by Region (2017-2022) & (US$ Million)
• Table 83. Asia Pacific Oral Transmucosal Drugs Revenue by Region (2023-2028) & (US$ Million)
• Table 84. Latin America Oral Transmucosal Drugs Sales by Type (2017-2022) & (K Units)
• Table 85. Latin America Oral Transmucosal Drugs Sales by Type (2023-2028) & (K Units)
• Table 86. Latin America Oral Transmucosal Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 87. Latin America Oral Transmucosal Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 88. Latin America Oral Transmucosal Drugs Sales by Application (2017-2022) & (K Units)
• Table 89. Latin America Oral Transmucosal Drugs Sales by Application (2023-2028) & (K Units)
• Table 90. Latin America Oral Transmucosal Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 91. Latin America Oral Transmucosal Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 92. Latin America Oral Transmucosal Drugs Sales by Country (2017-2022) & (K Units)
• Table 93. Latin America Oral Transmucosal Drugs Sales by Country (2023-2028) & (K Units)
• Table 94. Latin America Oral Transmucosal Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 95. Latin America Oral Transmucosal Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 96. Middle East and Africa Oral Transmucosal Drugs Sales by Type (2017-2022) & (K Units)
• Table 97. Middle East and Africa Oral Transmucosal Drugs Sales by Type (2023-2028) & (K Units)
• Table 98. Middle East and Africa Oral Transmucosal Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 99. Middle East and Africa Oral Transmucosal Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 100. Middle East and Africa Oral Transmucosal Drugs Sales by Application (2017-2022) & (K Units)
• Table 101. Middle East and Africa Oral Transmucosal Drugs Sales by Application (2023-2028) & (K Units)
• Table 102. Middle East and Africa Oral Transmucosal Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 103. Middle East and Africa Oral Transmucosal Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 104. Middle East and Africa Oral Transmucosal Drugs Sales by Country (2017-2022) & (K Units)
• Table 105. Middle East and Africa Oral Transmucosal Drugs Sales by Country (2023-2028) & (K Units)
• Table 106. Middle East and Africa Oral Transmucosal Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 107. Middle East and Africa Oral Transmucosal Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 108. LTS Lohmann Therapie-Systeme AG Corporation Information
• Table 109. LTS Lohmann Therapie-Systeme AG Description and Major Businesses
• Table 110. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 111. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 112. LTS Lohmann Therapie-Systeme AG Recent Developments
• Table 113. Soligenix Corporation Information
• Table 114. Soligenix Description and Major Businesses
• Table 115. Soligenix Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 116. Soligenix Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 117. Soligenix Recent Developments
• Table 118. ZIM Laboratories Limited Corporation Information
• Table 119. ZIM Laboratories Limited Description and Major Businesses
• Table 120. ZIM Laboratories Limited Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 121. ZIM Laboratories Limited Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 122. ZIM Laboratories Limited Recent Developments
• Table 123. Access Pharmaceutical Inc. Corporation Information
• Table 124. Access Pharmaceutical Inc. Description and Major Businesses
• Table 125. Access Pharmaceutical Inc. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 126. Access Pharmaceutical Inc. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 127. Access Pharmaceutical Inc. Recent Developments
• Table 128. C.L Pharm Corporation Information
• Table 129. C.L Pharm Description and Major Businesses
• Table 130. C.L Pharm Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 131. C.L Pharm Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 132. C.L Pharm Recent Developments
• Table 133. Cure Pharmaceutical Corporation Information
• Table 134. Cure Pharmaceutical Description and Major Businesses
• Table 135. Cure Pharmaceutical Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 136. Cure Pharmaceutical Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 137. Cure Pharmaceutical Recent Developments
• Table 138. Aquestive Therapeutics, Inc. Corporation Information
• Table 139. Aquestive Therapeutics, Inc. Description and Major Businesses
• Table 140. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 141. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 142. Aquestive Therapeutics, Inc. Recent Developments
• Table 143. NAL Pharma Corporation Information
• Table 144. NAL Pharma Description and Major Businesses
• Table 145. NAL Pharma Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 146. NAL Pharma Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 147. NAL Pharma Recent Developments
• Table 148. IntelGenx Corp. Corporation Information
• Table 149. IntelGenx Corp. Description and Major Businesses
• Table 150. IntelGenx Corp. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 151. IntelGenx Corp. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 152. IntelGenx Corp. Recent Developments
• Table 153. Eisai Co., Ltd. Corporation Information
• Table 154. Eisai Co., Ltd. Description and Major Businesses
• Table 155. Eisai Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 156. Eisai Co., Ltd. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 157. Eisai Co., Ltd. Recent Developments
• Table 158. Otsuka Pharmaceutical Co., Ltd. Corporation Information
• Table 159. Otsuka Pharmaceutical Co., Ltd. Description and Major Businesses
• Table 160. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 161. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 162. Otsuka Pharmaceutical Co., Ltd. Recent Developments
• Table 163. Teva Pharmaceutical Industries Ltd. Corporation Information
• Table 164. Teva Pharmaceutical Industries Ltd. Description and Major Businesses
• Table 165. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 166. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 167. Teva Pharmaceutical Industries Ltd. Recent Developments
• Table 168. GlaxoSmithKline plc Corporation Information
• Table 169. GlaxoSmithKline plc Description and Major Businesses
• Table 170. GlaxoSmithKline plc Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 171. GlaxoSmithKline plc Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 172. GlaxoSmithKline plc Recent Developments
• Table 173. Viatris Corporation Information
• Table 174. Viatris Description and Major Businesses
• Table 175. Viatris Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 176. Viatris Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 177. Viatris Recent Developments
• Table 178. Bristol-Myers Squibb Company Corporation Information
• Table 179. Bristol-Myers Squibb Company Description and Major Businesses
• Table 180. Bristol-Myers Squibb Company Oral Transmucosal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 181. Bristol-Myers Squibb Company Oral Transmucosal Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 182. Bristol-Myers Squibb Company Recent Developments
• Table 183. Key Raw Materials Lists
• Table 184. Raw Materials Key Suppliers Lists
• Table 185. Oral Transmucosal Drugs Distributors List
• Table 186. Oral Transmucosal Drugs Customers List
• Table 187. Oral Transmucosal Drugs Market Trends
• Table 188. Oral Transmucosal Drugs Market Drivers
• Table 189. Oral Transmucosal Drugs Market Challenges
• Table 190. Oral Transmucosal Drugs Market Restraints
• Table 191. Research Programs/Design for This Report
• Table 192. Key Data Information from Secondary Sources
• Table 193. Key Data Information from Primary Sources

List of Figures

• Figure 1. Oral Transmucosal Drugs Product Picture
• Figure 3. Global Oral Transmucosal Drugs Market Share by Type in 2021 & 2028
• Figure 3. Tablets Product Picture
• Figure 4. Films Product Picture
• Figure 5. Liquid Spray Product Picture
• Figure 6. Gels Product Picture
• Figure 7. Others Product Picture
• Figure 8. Global Oral Transmucosal Drugs Market Share by Application in 2021 & 2028
• Figure 9. Cardiovascular Disorders
• Figure 10. Acute Pain Managements
• Figure 11. Diabetes
• Figure 12. Others
• Figure 13. Oral Transmucosal Drugs Report Years Considered
• Figure 14. Global Oral Transmucosal Drugs Sales 2017-2028 (K Units)
• Figure 15. Global Oral Transmucosal Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 16. Global Oral Transmucosal Drugs Revenue 2017-2028 (US$ Million)
• Figure 17. Global Oral Transmucosal Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 18. Global Oral Transmucosal Drugs Sales Market Share by Region (2017-2022)
• Figure 19. Global Oral Transmucosal Drugs Sales Market Share by Region (2023-2028)
• Figure 20. North America Oral Transmucosal Drugs Sales YoY (2017-2028) & (K Units)
• Figure 21. North America Oral Transmucosal Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 22. Europe Oral Transmucosal Drugs Sales YoY (2017-2028) & (K Units)
• Figure 23. Europe Oral Transmucosal Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 24. Asia-Pacific Oral Transmucosal Drugs Sales YoY (2017-2028) & (K Units)
• Figure 25. Asia-Pacific Oral Transmucosal Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 26. Latin America Oral Transmucosal Drugs Sales YoY (2017-2028) & (K Units)
• Figure 27. Latin America Oral Transmucosal Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 28. Middle East & Africa Oral Transmucosal Drugs Sales YoY (2017-2028) & (K Units)
• Figure 29. Middle East & Africa Oral Transmucosal Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 30. The Oral Transmucosal Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 31. The Top 5 and 10 Largest Manufacturers of Oral Transmucosal Drugs in the World: Market Share by Oral Transmucosal Drugs Revenue in 2021
• Figure 32. Global Oral Transmucosal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 33. Global Oral Transmucosal Drugs Sales Market Share by Type (2017-2028)
• Figure 34. Global Oral Transmucosal Drugs Revenue Market Share by Type (2017-2028)
• Figure 35. Global Oral Transmucosal Drugs Sales Market Share by Application (2017-2028)
• Figure 36. Global Oral Transmucosal Drugs Revenue Market Share by Application (2017-2028)
• Figure 37. North America Oral Transmucosal Drugs Sales Market Share by Type (2017-2028)
• Figure 38. North America Oral Transmucosal Drugs Revenue Market Share by Type (2017-2028)
• Figure 39. North America Oral Transmucosal Drugs Sales Market Share by Application (2017-2028)
• Figure 40. North America Oral Transmucosal Drugs Revenue Market Share by Application (2017-2028)
• Figure 41. North America Oral Transmucosal Drugs Sales Share by Country (2017-2028)
• Figure 42. North America Oral Transmucosal Drugs Revenue Share by Country (2017-2028)
• Figure 43. United States Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 44. Canada Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 45. Europe Oral Transmucosal Drugs Sales Market Share by Type (2017-2028)
• Figure 46. Europe Oral Transmucosal Drugs Revenue Market Share by Type (2017-2028)
• Figure 47. Europe Oral Transmucosal Drugs Sales Market Share by Application (2017-2028)
• Figure 48. Europe Oral Transmucosal Drugs Revenue Market Share by Application (2017-2028)
• Figure 49. Europe Oral Transmucosal Drugs Sales Share by Country (2017-2028)
• Figure 50. Europe Oral Transmucosal Drugs Revenue Share by Country (2017-2028)
• Figure 51. Germany Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 52. France Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 53. U.K. Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 54. Italy Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 55. Russia Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 56. Asia Pacific Oral Transmucosal Drugs Sales Market Share by Type (2017-2028)
• Figure 57. Asia Pacific Oral Transmucosal Drugs Revenue Market Share by Type (2017-2028)
• Figure 58. Asia Pacific Oral Transmucosal Drugs Sales Market Share by Application (2017-2028)
• Figure 59. Asia Pacific Oral Transmucosal Drugs Revenue Market Share by Application (2017-2028)
• Figure 60. Asia Pacific Oral Transmucosal Drugs Sales Share by Region (2017-2028)
• Figure 61. Asia Pacific Oral Transmucosal Drugs Revenue Share by Region (2017-2028)
• Figure 62. China Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 63. Japan Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 64. South Korea Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 65. India Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 66. Australia Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 67. China Taiwan Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 68. Indonesia Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 69. Thailand Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 70. Malaysia Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 71. Latin America Oral Transmucosal Drugs Sales Market Share by Type (2017-2028)
• Figure 72. Latin America Oral Transmucosal Drugs Revenue Market Share by Type (2017-2028)
• Figure 73. Latin America Oral Transmucosal Drugs Sales Market Share by Application (2017-2028)
• Figure 74. Latin America Oral Transmucosal Drugs Revenue Market Share by Application (2017-2028)
• Figure 75. Latin America Oral Transmucosal Drugs Sales Share by Country (2017-2028)
• Figure 76. Latin America Oral Transmucosal Drugs Revenue Share by Country (2017-2028)
• Figure 77. Mexico Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 78. Brazil Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 79. Argentina Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 80. Middle East and Africa Oral Transmucosal Drugs Sales Market Share by Type (2017-2028)
• Figure 81. Middle East and Africa Oral Transmucosal Drugs Revenue Market Share by Type (2017-2028)
• Figure 82. Middle East and Africa Oral Transmucosal Drugs Sales Market Share by Application (2017-2028)
• Figure 83. Middle East and Africa Oral Transmucosal Drugs Revenue Market Share by Application (2017-2028)
• Figure 84. Middle East and Africa Oral Transmucosal Drugs Sales Share by Country (2017-2028)
• Figure 85. Middle East and Africa Oral Transmucosal Drugs Revenue Share by Country (2017-2028)
• Figure 86. Turkey Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 87. Saudi Arabia Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 88. UAE Oral Transmucosal Drugs Revenue (2017-2028) & (US$ Million)
• Figure 89. Oral Transmucosal Drugs Value Chain
• Figure 90. Oral Transmucosal Drugs Production Process
• Figure 91. Channels of Distribution
• Figure 92. Distributors Profiles
• Figure 93. Bottom-up and Top-down Approaches for This Report
• Figure 94. Data Triangulation
• Figure 95. Key Executives Interviewed